Patent · US Active

Compositions comprising dexamethasone

US10537585B2 · kind B2 · utility

0Cited by
56References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2017
Grant dateJan 21, 2020
Priority date
Expiry dateDec 18, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P7/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A pharmaceutical composition useful for the treatment of multiple myeloma in combination with an anti-cancer drug is provided. The pharmaceutical composition includes high-dose dexamethasone or a pharmaceutically acceptable salt or solvate thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.